Dr. Escolar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4401 Penn Avenue
Pittsburgh, PA 15224- Is this information wrong?
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1989 - 1993
- Escuela Colombiana de MedicinaClass of 1986
Certifications & Licensure
- PA State Medical License 2011 - 2024
- NC State Medical License 1998 - 2012
- NY State Medical License 1993 - 2000
Clinical Trials
- The Natural History of Metachromatic Leukodystrophy Start of enrollment: 2012 Jan 01
- Diffusion Tensor Imaging (DTI) in Infants With Krabbe Disease Start of enrollment: 2008 Apr 01
- The Natural History of Infantile Globoid Cell Leukodystrophy Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Consensus guidelines for the monitoring and management of metachromatic leukodystrophy in the United States.Laura A Adang, Joshua L Bonkowsky, Jaap Jan Boelens, Eric Mallack, Rebecca Ahrens-Nicklas, John A Bernat, Annette Bley, Barbara Burton, Alejandra Darling, Florian Eich...> ;Cytotherapy. 2024 Apr 1
- Combination HSCT and intravenous AAV-mediated gene therapy in a canine model proves pivotal for translation of Krabbe disease therapy.Allison M Bradbury, Jessica Bagel, Gary Swain, Keiko Miyadera, Jill P Pesayco, Charles-Antoine Assenmacher, Becky Brisson, Ian Hendricks, Xiao H Wang, Zachary Herbst, ...> ;Molecular Therapy. 2024 Jan 3
- 4 citationsAdeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation.Manuela Corti, Barry J Byrne, Dominic J Gessler, Grace Thompson, Samantha Norman, Jenna Lammers, Kirsten E Coleman, Cristina Liberati, Melissa E Elder, Maria L Escolar...> ;Molecular Therapy. Methods & Clinical Development. 2023 Sep 14
- Join now to see all
Press Mentions
- Forge Biologics Reports Positive FBX-101 Clinical Updates for Patients with Krabbe Disease at WORLDSymposiumFebruary 23rd, 2023
- Forge Biologics Announces Updated Positive Clinical Data in RESKUE, a Novel Phase 1/2 Gene Therapy Trial for Patients with Krabbe DiseaseOctober 11th, 2022
- Forge Biologics Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients with Krabbe Disease at the SSIEM Annual SymposiumAugust 30th, 2022
- Join now to see all
Grant Support
- DTI As A Tool To Identify Infants With Krabbe Disease In Need Of Urgent TreatmentNational Institute Of Neurological Disorders And Stroke2011–2012
- DTI As A Tool To Identify Infants With Krabbe Disease In Need Of Urgent TreatmentNational Institute Of Neurological Disorders And Stroke2008–2011
Hospital Affiliations
- UPMC Children's Hospital of PittsburghPittsburgh, Pennsylvania
- UPMC Presbyterian ShadysidePittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: